RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells

Journal of Virology

Volumn 75, Issue 20, 2001, Pages 9872-9884

  Jenkins, H L ^a   Spencer, C A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOLOENZYME; PHOSPHOTRANSFERASE; RNA POLYMERASE II; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME MODIFICATION; ENZYME SUBUNIT; GENE REPRESSION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HELA CELLS; HERPESVIRUS 1, HUMAN; HOLOENZYMES; HUMANS; IMMEDIATE-EARLY PROTEINS; PHOSPHORYLATION; RNA POLYMERASE II; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0034812851     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.20.9872-9884.2001     Document Type: Article

References (72)

1. Stimulation of transcript elongation requires both the zinc finger and RNA polymerase II binding domains of human TFIIS
2. Contact with a component of the polymerase II holoenzyme suffices for gene activation
3. Coupling RNA polymerase II transcription with pre-mRNA processing
4. A minimal set of RNA polymerase II transcription protein interactions
5. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency
6. Interaction of the viral activator protein ICP4 with TFIID through TAF250
7. A multiplicity of mediators: Alternative forms of transcription complexes communicate with transcriptional regulators
8. Affinity purification of a human RNA polymerase II complex using monoclonal antibodies against transcription factor IIF
9. Transcription elongation and human disease
10. Reversible phosphorylation of the C-terminal domain of RNA polymerase II
11. Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein
12. Comparison of the intranuclear distributions of herpes simplex virus proteins involved in various viral functions
13. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4
14. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
15. A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes
16. ICP0, a regulator of herpes simplex virus during lytic and latent infection
17. Gene activation by recruitment of the RNA polymerase II holoenzyme
18. On the control of immediate early (α) mRNA survival in cells infected with herpes simplex virus
19. RNA polymerase II holoenzyme recruitment is sufficient to remodel chromatin at the yeast PHO5 promoter
20. Transcriptional control of herpes-virus gene expression: Gene functions required for positive and negative regulation
21. Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II
22. RNA polymerase II holoenzyme and transcriptional regulation
23. Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA
24. RNA polymerase II as a control panel for multiple coactivator complexes
25. Herpes simplex virus types 1 and 2 induce shutoff of host protein synthesis by different mechanisms in Friend erythroleukemia cells
26. RNA polymerase II and the integration of nuclear events
27. The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA
28. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH
29. Monoclonal antibody directed against RNA polymerase II of Drosophila melanogaster
30. A regulatory shortcut between the Snf1 protein kinase and RNA polymerase II holoenzyme
31. Analysis of HCF, the cellular cofactor of VP16, in herpes simplex virus-infected cells
32. Two-dimensional crystallography of TFIIB- and IIE-RNA polymerase II complexes: Implications for start site selection and initiation complex formation
33. ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II
34. A human RNA polymerase II complex associated with SRB and DNA-repair proteins
35. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase
36. Differential stability of host mRNAs in Friend erythroleukemia cells infected with herpes simplex virus type 1
37. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription
38. Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast
39. RNA helicase A mediates association of CBP with RNA polymerase II
40. Factors associated with the mammalian RNA polymerase II holoenzyme
41. The virion transactivator of herpes simplex virus
42. Analysis of the role of TFIIE in transcriptional regulation through structure-function studies of the TFIIE β subunit
43. An RNA polymerase II complex containing all essential initiation factors binds to the activation domain of PAR leucine zipper transcription factor thyroid embryonic factor
44. A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation
45. Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activators
46. Regulatory targets in the RNA polymerase II holoenzyme
47. Nuclear sites of herpes simplex virus type 1 DNA replication and transcription colocalize at early times postinfection and are largely distinct from RNA processing factors
48. Intranuclear localization of herpes simplex virus immediate-early and delayed-early proteins: Evidence that ICP4 is associated with progeny virus DNA
49. Genetic evidence for two distinct trans-activation functions of the herpes simplex virus α protein ICP27
50. Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program
51. RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection
52. Localization of subunits of transcription factors IIE and IIF immediately upstream of the transcriptional initiation site of the adenovirus major late promoter
53. Nuclear RNA polymerases: Role of general initiation factors and cofactors in eukaryotic transcription
54. Herpes simplex viruses and their replication
55. BRCA1 is a component of the RNA polymerase II holoenzyme
56. Mammalian RNA polymerase 1 exists as a holoenzyme with associated basal transcription factors
57. An oligomeric form of the large subunit of transcription factor (TF) IIE activates phosphorylation of the RNA polymerase II carboxyl-terminal domain by TFIIH
58. A high-efficiency HeLa cell nuclear transcription extract
59. Differential regulation of endogenous and transduced β-globin genes during infection of erythroid cells with a herpes simplex virus type 1 recombinant
60. The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection
61. Regulation of cellular genes by HSV products
62. ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB
63. Isolation of three proteins that bind to mammalian RNA polymerase II
64. Repression of host RNA polymerase II transcription by herpes simplex virus type 1
65. Mitotic transcription repression in vivo in the absence of nucleosomal chromatin condensation
66. Herpes simplex virus-induced changes in cellular and adenovirus RNA metabolism in an adenovirus type 5-transformed human cell line
67. General requirement for RNA polymerase II holoenzymes in vivo
68. Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography. Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody
69. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH
70. Identification of an autonomously initiating RNA polymerase III holoenzyme containing a novel factor that is selectively inactivated during protein synthesis inhibition
71. Transcriptional and post-transcriptional controls establish the cascade of herpes simplex virus protein synthesis
72. MCM proteins are associated with RNA polymerase II holoenzyme